ASHLEY DUNCAN: Open Payments
NPI 1649888413 · WYNNE, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$461 in 22 payments from 12 companies in 2025. Trend: 2023 $253 · 2024 $321 · 2025 $461
Food & beverage: $461
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 2 | $131 |
| ABBVIE INC. | 3 | $58 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $45 |
| Novo Nordisk Inc | 3 | $43 |
| AstraZeneca Pharmaceuticals LP | 2 | $34 |
| Exact Sciences Corporation | 2 | $30 |
| Mannkind Corporation | 1 | $25 |
| CVRx, Inc. | 1 | $21 |
| Lundbeck LLC | 1 | $20 |
| Phathom Pharmaceuticals, Inc. | 2 | $20 |
Products named: REPATHA, CAPLYTA, BREZTRI, QULIPTA, AFREZZA, Barostim Neo System, REXULTI, VOQUEZNA.
Industry payments across AR — which companies pay providers there.
